Financhill
Back

BridgeBio Pharma Stock Predictions

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 44% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $33.84. The Score for BBIO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 44% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
42
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
39.54
52-Week Low:
21.62

Prediction Charts

Market Cap:
6.4B
Price in USD:
33.84
Volume:
2.6M
Beta:
1.07

Technical Analysis

SMA50:
34.41
SMA100:
33.45
SMA200:
29.64
52-Wk Change:
9.02%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 33.84 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 36.05 36.42 37.05 35.67
Apr-30 38.61 38.36 39.54 37.24
May-1 38.29 38.40 38.62 36.85
May-2 38.85 38.57 39.16 38.12
May-5 38.73 38.22 38.73 37.76
May-6 37.84 36.94 38.01 36.21
May-7 36.94 35.82 37.03 35.44
May-8 35.63 34.85 35.75 33.92
May-9 35.43 34.17 35.60 34.15
May-12 34.54 35.68 36.11 34.26
May-13 34.73 33.26 34.84 33.21
May-14 33.33 33.66 34.05 32.90
May-15 33.74 33.74 34.02 33.24
May-16 33.82 33.84 34.16 33.57

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.22 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.